IGENZ Ltd, Level 2, Quay Park Health, Auckland 1010, New Zealand.
Transl Pediatr. 2015 Apr;4(2):116-24. doi: 10.3978/j.issn.2224-4336.2015.03.02.
Genetic changes, in particular chromosomal aberrations, are a hallmark of acute lymphoblastic lymphoma (ALL) and accurate detection of them is important in ensuring assignment to the appropriate drug protocol. Our ability to detect these genetic changes has been somewhat limited in the past due to the necessity to analyse mitotically active cells by conventional G-banded metaphase analysis and by mutational analysis of individual genes. Advances in technology include high resolution, microarray-based techniques that permit examination of the whole genome. Here we will review the current available methodology and discuss how the technology is being integrated into the diagnostic setting.
遗传变化,尤其是染色体异常,是急性淋巴细胞白血病 (ALL) 的一个标志,准确检测这些变化对于确保分配到适当的药物方案非常重要。由于过去需要通过常规的 G 带中期分析和个别基因的突变分析来分析有丝分裂活性细胞,因此我们检测这些遗传变化的能力有些受限。技术的进步包括高分辨率、基于微阵列的技术,可用于检查整个基因组。在这里,我们将回顾当前可用的方法,并讨论该技术如何融入诊断环境。